ThoroughCare | $5,000,000 | (Nov 20, 2024)
OneChronos | $32,000,000 | (Nov 20, 2024)
EarthOptics | $24,000,000 | (Nov 20, 2024)
Certified by Founder
Lodge
Valo Therapeutics Ltd
start up
Finland
- Helsinki, Uusimaa
- 15/11/2021
- Unknown
- $12,500,000
Valo Therapeutics (ValoTx) is a developer of novel immunotherapies in cancer and infectious disease. Our unique approach to immunotherapy, based on oncolytic viruses and viral vectors combined with disease-specific peptides, delivers highly adaptable and immunogenic therapeutic vaccination platforms. A spin-out company from the University of Helsinki, Finland, Valo Tx has assembled a talented team of immunotherapy experts, who together with the founding scientists have the necessary expertise to take its patented technology through clinical development and make it available to patients. The management team has a proven track record of developing successful companies from a laboratory idea to a full stock exchange listing.
- Industry Biotechnology Research
- Website http://www.valotx.com/
- LinkedIn https://www.linkedin.com/company/valo-therapeutics/
Citizen Health | $14,500,000 | (Nov 20, 2024)
Kong Inc. | $175,000,000 | (Nov 20, 2024)
RIIG | $3,000,000 | (Nov 20, 2024)
OSYTE [O-Sight] | $4,000,000 | (Nov 20, 2024)
Levanta | $20,000,000 | (Nov 20, 2024)
Jimini Health | $8,000,000 | (Nov 20, 2024)
Kalder | $10,500,000 | (Nov 20, 2024)
Lightsynq | $18,000,000 | (Nov 20, 2024)
ChapsVision | $90,000,000 | (Nov 19, 2024)